Information for FLOW trial
Page information·measured at build time
Technical and provenance information about FLOW trial. All figures on this page are measured from the emitted page rather than declared.
Basic information
| Display title | FLOW trial |
|---|---|
| Default sort key | FLOW trial |
| Namespace | Article (main) |
| Page kind | Concept |
| Page length (source, bytes) | 4,583 |
| Rendered word count | 547 |
| Internal wiki links on the page | 13 |
| Defined citations | 4 |
| Top-level sections | 3 |
| Subsections | 0 |
| Tables | 1 |
| Figures | 0 |
| Infobox | Yes — concept |
| Maintenance banners | None |
| Indexing by robots | Allowed |
Edit history
| Page creator | LurkerLevi |
|---|---|
| Date of page creation | 23 September 2024 |
| Latest editor | GradientGus |
| Date of latest edit | 18 July 2026 |
| Total number of edits | 31 |
| Total number of distinct authors | 25 |
| Minor edits | 12 |
| Automated (bot) edits | 8 |
| Recent number of edits (last 90 days) | 3 |
| Talk page posts | 4 |
Principal authors
| Editor | Edits | Share | Declared focus |
|---|---|---|---|
| CategoryBot | 3 | 9.7% | categorisation and navigation |
| PioneerPerdita | 2 | 6.5% | clinical trials and evidence appraisal |
| SurpassSunniva | 2 | 6.5% | clinical trials and evidence appraisal |
| CiteBot | 2 | 6.5% | copy-editing and the manual of style |
| StubSorterBot | 2 | 6.5% | categorisation and navigation |
| LurkerLevi | 1 | 3.2% | policy, notability and deletion |
| LeanMassLars | 1 | 3.2% | adverse effects and clinical safety |
| LotTraceLuka | 1 | 3.2% | third-party testing and certificates of analysis |
| TirzTaxonomist | 1 | 3.2% | GLP-1 receptor agonists and related compounds |
| GramsNotUnitsGil | 1 | 3.2% | dosing, titration and injection practice |
| StyleSheetSybil | 1 | 3.2% | copy-editing and the manual of style |
| HedgeHedda | 1 | 3.2% | copy-editing and the manual of style |
Category membership
- Category:Renal outcome trials — 1 member pages
- Category:Clinical evidence — 11 member pages
- Category:Type 2 diabetes trials — 4 member pages